WAVE Life Sciences Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$227.8M
Industry:Biotech
Founded:N/A
Lead Investor(s):Teva
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • WAVE Life Sciences's estimated annual revenue is currently $41.9M per year.
  • WAVE Life Sciences received $93.4M in venture funding in April 2017.
  • WAVE Life Sciences's estimated revenue per employee is $155,000
  • WAVE Life Sciences's total funding is $227.8M.

Employee Data

  • WAVE Life Sciences has 270 Employees.
  • WAVE Life Sciences grew their employee count by 33% last year.
  • WAVE Life Sciences currently has 36 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ohana Bioscienc...
$8.7M5660%N/A
Tango Therapeut...
$12.9M8338%N/A
Compass Therape...
$16.4M10614%N/A
Cell Signaling ...
$89.4M577N/AN/A
Momenta Pharmac...
N/A220N/AN/A
Emulate
$15.3M99-17%N/A
ArQule
N/A94N/AN/A
Hamilton Storag...
$17.2M1119%N/A
Alnylam Pharmac...
$74.9M127731%N/A
Transgenomic
N/A47N/AN/A
Missing a competitor? Contribute!?
Submit

Wave Life Sciences Ltd. (NASDAQ: WVE) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. Given the unique versatility of its chemistry platform, Wave's pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.

keywords:Biotechnology,Healthcare,Pharmaceuticals

270

Number of Employees

$41.9M

Revenue (est)

36

Current Jobs

33%

Employee Growth %

$227.8M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Executive Contacts

NameTitleEmail
James TolerAssociate Director Non-Clinical Outsourcing
David GaieroVice President, Corporate Controller
Pallavi LonkarDirector Bioanalytical, Biomarker
Kenneth LongoSenior Director, Data Science
Michael ByrneDirector Of In Vivo Biology And Ophthalmology
Karen NeedhamManager Payroll & Equity
Raj DasariAssociate Director
Subbu MarappanPrincipal ScientistEmail Available
Derek RhodesSenior Director, Development IT
Mark McLaughlinDirector of Statistical Programming

WAVE Life Sciences News

24-Aug-19 - Wave Life Sciences to Present at the Morgan Stanley Global ...

CAMBRIDGE, Mass., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines ...

07-Sep-19 - Wave Life Sciences to Host Analyst and Investor Research Day on October 7, 2019

06, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (WVE), a clinical-stage genetic medicines company committed to delivering ...

07-Sep-19 - Wave Life Sciences (NASDAQ:WVE) Cut to “Sell” at BidaskClub

Wave Life Sciences (NASDAQ:WVE) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note ...

WAVE Life Sciences Funding

DateAmountRoundLead InvestorsReference
2015-02-03$18.0MARA Capital Management LLCArticle
2015-08-19$66.0MBForesite CapitalArticle
2015-12-16$30.0MUndisclosedTevaArticle
2017-04-13$93.4MUndisclosedMultipleArticle

WAVE Life Sciences Executive Hires

DateNameTitleReference
2015-04-08Roberto GuercioliniSVP/Head of Early DevelopmentArticle
2016-07-13Michael PanzaraHead Of Neurology FranchiseArticle
2016-08-18Keith RegnanteCFOArticle

WAVE Life Sciences New Location/Offices

DateLocationReference
2017-10-27Boston, MAArticle